-transparent.png){kind=logo}
METHODS A young boy with hyper-immunoglobulin M (IgM) syndrome had recurrent severe infections, failure to thrive, and chronic neutropenia for 2 years despite treatment with i.v. gammaglobulin (IVIG). RESULTS With the addition of granulocyte colony-stimulating factor (G-CSF; Filgrastim, Amgen, Inc., Thousand Oaks, CA), increased doses of IVIG, and prophylactic trimethoprim-sulfamethoxazole, his absolute neutrophil count increased from 0.64 x 10(9)/L to 3.36 x 10(9)/L, and he has been free of significant infection for the past 22 months. CONCLUSIONS The use of G-CSF merits consideration in patients with hyper-IgM syndrome and severe neutropenia.
Related Publications
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
October 1995,
Orvosi hetilap,
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
March 1994,
British journal of haematology,
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
April 1997,
British journal of haematology,
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
May 1989,
The New England journal of medicine,
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
February 1991,
Annals of hematology,
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
December 1990,
Arthritis and rheumatism,
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
November 1996,
Anales espanoles de pediatria,
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
January 1995,
Archives of disease in childhood. Fetal and neonatal edition,
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
December 1994,
The Journal of pediatrics,
W C Wang, and
J Cordoba, and
A J Infante, and
M E Conley
January 2000,
Gaceta medica de Mexico,
